Atlas Trials

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Clinical trial NCT04510597 · RECRUITING

Trial details

NCT number
NCT04510597
Sponsor
SWOG Cancer Research Network
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
Start date
2021-03-08
Primary completion
2033-07-01
Enrollment
364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.